How to prevent nosocomial infection during pulmonary function tests

E. Verin, C. Chefson, J. F. Lemeland, A. M. Leroi, M. Nouvellon, P. Denis (Rouen, France)

Source: Annual Congress 2003 - Respiratory in primary care
Session: Respiratory in primary care
Session type: Thematic Poster Session
Number: 2801

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Verin, C. Chefson, J. F. Lemeland, A. M. Leroi, M. Nouvellon, P. Denis (Rouen, France). How to prevent nosocomial infection during pulmonary function tests. Eur Respir J 2003; 22: Suppl. 45, 2801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia
Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas!
Year: 2009


Prevention of nosocomial infections in acute respiratory failure patients
Source: Eur Respir J 2003; 22: 72S-76S
Year: 2003



Age-related pattern of childhood lung infection and its complications
Source: ISSN=1025-448x, ISBN=1-904097-22-7, page=189
Year: 2002

The prevalence of mycobacterial and fungal pulmonary infections in patients submitted to hepatic transplant
Source: Eur Respir J 2004; 24: Suppl. 48, 702s
Year: 2004

Impact of appropriate diagnostics on the management of respiratory tract infections
Source: Value-Dx event 2021: Community-acquired respiratory tract infections: where do we stand in 2021, ECCMID 2021
Year: 2021

The clinical evaluation of respiratory tract infection caused by MRSA
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010

Pulmonary complications of HIV infection
Source: Annual Congress 2007 - ACCP 2 - Pulmonary complications of HIV infection
Year: 2007

Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021


Can procalcitonin testing reduce antibiotic prescribing for respiratory infections?
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Restricted visiting reduces nosocomial viral respiratory tract infections in high-risk neonates
Source: Eur Respir J, 53 (3) 1801874; 10.1183/13993003.01874-2018
Year: 2019



Pulmonary fibrosis in mice increases susceptibility to pneumococcal pneumonia and bacteremia
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Treatment of community-acquired lower respiratory tract infections in adults
Source: Eur Respir J 2002; 20: 40S-53S
Year: 2002



Prevalence of CNS lesions in patients with pulmonary tuberculosis and HIV infection
Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Year: 2019


Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients
Source: Eur Respir J 2001; 17: 87-93
Year: 2001



Intrapulmonary penetration of antimicrobials and implications in the treatment of lower respiratory tract infections
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=13
Year: 2004

Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


The need of a minimal set of tests to identify mycobacterium species isolated from lower tract respiratory infections
Source: Eur Respir J 2007; 30: Suppl. 51, 662s
Year: 2007